We are live on ! Find out more
BGMS icon

Bio Green Med Solution

22 hedge funds and large institutions have $10.1M invested in Bio Green Med Solution in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more capital inflows, than outflows

Capital inflows: $862K | Capital outflows: $513K

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

0.78% more ownership

Funds ownership: 32.46% → 33.24% (+0.78%)

12% less funds holding

Funds holding: 25 → 22 (-3)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
22
Holders Change
-3
Holders Change %
-12%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
3
Closed
5
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
+$42K

BGMS Hedge Fund Activity: Q1 2022 in Review

22 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution (BGMS) for Q1 2022, worth a combined $10.1M — down 20% from $12.6M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of BGMS and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 5 added.

The largest buyer was Schonfeld Strategic Advisors, adding an estimated $643K. The largest seller was Two Sigma Advisers, cutting an estimated $170K.

  • 22 institutional investors held Bio Green Med Solution (BGMS) as of Q1 2022, down from 25 in Q4 2021.
  • Funds reported $10.1M of Bio Green Med Solution stock for Q1 2022, down 20% quarter-over-quarter.
  • 3 funds opened new Bio Green Med Solution positions in Q1 2022 and 5 closed out, a net change of -2 holders.
  • The largest Bio Green Med Solution buyer in Q1 2022 was Schonfeld Strategic Advisors, an estimated $643K added.
  • The largest Bio Green Med Solution seller in Q1 2022 was Two Sigma Advisers, an estimated $170K sold.

Based on aggregated 13F filings for Q1 2022.